This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (196) Neurology and Neurosciences (103) Safety and Error Prevention in Health (148) Wearable Devices and Sensors (570)

Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Authors of this article:

Fatima Jamali 1 Author Orcid Image ;   Mayis Aldughmi 2 Author Orcid Image ;   Mohammad W Khasawneh 1 Author Orcid Image ;   Said Dahbour 3, 4 Author Orcid Image ;   Alaa A Salameh 1 Author Orcid Image ;   Abdalla Awidi 1, 5 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref.